National Cancer Institute
Found 1829 results for your search:
Total relevant funding to Breast for this search:
$520,138,871
Fiscal Year FY 2016
Cancer Type [Breast]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 1829 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(1/2) University of Guam/University of Hawaii Cancer Center Partnership 5U54CA143727-07 $1,275,740 $229,633 PALAFOX, NEAL UNIVERSITY OF HAWAII AT MANOA
2
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities 5U54CA143930-07 $730,767 $321,537 FARIAS-EISNER, ROBIN UNIVERSITY OF CALIFORNIA LOS ANGELES
3
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer. 1R01CA206025-01 $655,037 $655,037 GUISE, THERESA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
4
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer 1R01CA205632-01 $469,489 $469,489 RIEGEL, ANNA GEORGETOWN UNIVERSITY
5
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity 1R01CA205101-01 $406,070 $406,070 SKALA, MELISSA MORGRIDGE INSTITUTE FOR RESEARCH, INC.
6
(PQ8) BONE MARROW-ON-A-CHIP"":AN INVITRO 3D MODEL OF BREAST CANCER DORMANCY 1R21CA208519-01 $165,844 $165,844 GEORGE, STEVEN WASHINGTON UNIVERSITY
7
(PQ9) A novel mechanism of paclitaxel-induced peripheral neuropathy and potential treatment 1R01CA208765-01 $351,874 $351,874 YANG, QING UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
8
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae 1R01CA208634-01 $560,277 $280,139 JURECIC, ROLAND UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
9
(PQ9) Dual Action RSK Inhibitor: Targeting Metastasis and Providing Cardioprotection 1R21CA208631-01 $251,120 $251,120 LANNIGAN, DEBORAH VANDERBILT UNIVERSITY MEDICAL CENTER
10
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle 7R21CA205437-02 $152,333 $152,333 WANING, DAVID PENNSYLVANIA STATE UNIV HERSHEY MED CTR
11
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle. 1R21CA205437-01 $51,247 $51,247 WANING, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
12
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy 1R01CA205255-01 $577,463 $577,463 SEGAL, ROSALIND DANA-FARBER CANCER INST
13
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise 4R01CA179963-04 $513,435 $513,435 BRYAN, ANGELA UNIVERSITY OF COLORADO
14
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell 4R01CA180033-04 $295,065 $295,065 MISKIMINS, W SANFORD RESEARCH/USD
15
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival 5R01CA184953-03 $602,462 $602,462 CAAN, BETTE KAISER FOUNDATION RESEARCH INSTITUTE
16
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b 5R01CA185293-03 $329,112 $329,112 FISCHBACH, CLAUDIA CORNELL UNIVERSITY
17
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK? 5R01CA180070-05 $339,116 $339,116 HEBER-KATZ, ELLEN LANKENAU INSTITUTE FOR MEDICAL RESEARCH
18
(PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause 5R01CA185530-03 $367,275 $367,275 MOSES, MARSHA CHILDREN'S HOSPITAL CORPORATION
19
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk 4R01CA179977-04 $816,993 $408,497 KERR, JACQUELINE UNIVERSITY OF CALIFORNIA SAN DIEGO
20
(PQB-4) Opposing Effects of the SASP in Cancer Progression 5R01CA184572-03 $329,925 $108,875 HERBIG, UTZ RBHS-NEW JERSEY MEDICAL SCHOOL
21
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors 5R01CA194470-02 $464,569 $153,308 JANES, KEVIN UNIVERSITY OF VIRGINIA
22
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis 5R01CA185363-03 $318,250 $318,250 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH
23
(PQC3) Ethnicity-determined immune response and DCIS outcome 5R01CA194600-02 $684,967 $684,967 BADVE, SUNIL INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
24
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS 5R01CA185138-03 $490,842 $490,842 HWANG, EUN-SIL DUKE UNIVERSITY
25
(PQC4) Fate of cells disseminating from human breast cancer xenografts 4R01CA180039-04 $328,888 $328,888 WERB, ZENA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
26
(PQC6) Molecular Determinants of Quiescent Cancer Cells 5R01CA185086-03 $488,316 $488,316 RAMASWAMY, SRIDHAR MASSACHUSETTS GENERAL HOSPITAL
27
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ 5R01CA194697-02 $347,700 $347,700 ZHANG, SIYUAN UNIVERSITY OF NOTRE DAME
28
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS 4R01CA180061-04 $410,757 $410,757 WOODWARD, WENDY UNIVERSITY OF TX MD ANDERSON CAN CTR
29
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care 5R01CA190016-03 $802,301 $802,301 NATTINGER, ANN MEDICAL COLLEGE OF WISCONSIN
30
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer 5R01CA195904-02 $568,802 $568,802 MURPHY, WILLIAM UNIVERSITY OF CALIFORNIA AT DAVIS
31
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership 1P20CA202924-01A1 $234,900 $152,685 WILLIAMS, KEVIN NORTH CAROLINA CENTRAL UNIVERSITY
32
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership 5U54CA132379-07 $1,293,750 $284,625 MARTINEZ, MARIA UNIVERSITY OF CALIFORNIA SAN DIEGO
33
1/2 The GUIDE Cancer Research Training Project 5P20CA202908-02 $224,260 $224,260 WINN, ROBERT UNIVERSITY OF ILLINOIS AT CHICAGO
34
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 3U54CA203000-02S1 $25,000 $13,750 SIMON, MELISSA NORTHWESTERN UNIVERSITY AT CHICAGO
35
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 5U54CA203000-02 $1,377,921 $757,857 SIMON, MELISSA NORTHWESTERN UNIVERSITY AT CHICAGO
36
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership 1P20CA202925-01A1 $259,367 $62,248 PATIERNO, STEVEN DUKE UNIVERSITY
37
2/2 NCCU-LCCC Partnership in Cancer Research 5U54CA156733-07 $997,277 $279,238 EARP, HENRY UNIV OF NORTH CAROLINA CHAPEL HILL
38
2/2 The GUIDE Cancer Research Training Project 3P20CA202907-02S1 $52,412 $52,412 BALTHAZAR, CATHERINE GOVERNORS STATE UNIVERSITY
39
2/2 The GUIDE Cancer Research Training Project 5P20CA202907-02 $174,056 $174,056 BALTHAZAR, CATHERINE GOVERNORS STATE UNIVERSITY
40
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 2U54CA118623-11 $1,134,399 $317,632 TROY, ROBERTA TUSKEGEE UNIVERSITY
41
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 3U54CA202995-02S1 $39,000 $14,430 CIECIERSKI, CHRISTINA NORTHEASTERN ILLINOIS UNIVERSITY
42
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 5U54CA202995-02 $829,677 $306,980 CIECIERSKI, CHRISTINA NORTHEASTERN ILLINOIS UNIVERSITY
43
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis 5R00CA172357-05 $240,780 $240,780 NELSON, ERIK UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
44
3-D modeling-based decision support for optimizing quality of life following breast reconstruction 1R01CA203984-01 $687,629 $687,629 MARKEY, MIA UNIVERSITY OF TEXAS, AUSTIN
45
3-dimensional circulating miRNA expression profile for early breast cancer detection 3R01CA188991-02S1 $55,906 $55,906 ZHONG, WENWAN UNIVERSITY OF CALIFORNIA RIVERSIDE
46
3-Dimensional profile of circulating miRNA for early cancer detection 5R01CA188991-02 $308,434 $308,434 ZHONG, WENWAN UNIVERSITY OF CALIFORNIA RIVERSIDE
47
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 2U54CA118948-11 $1,337,658 $26,753 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
48
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 3U54CA118948-11S1 $162,279 $14,605 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
49
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 3U54CA202997-02S1 $250,000 $15,000 WINN, ROBERT UNIVERSITY OF ILLINOIS AT CHICAGO
50
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity 5U54CA202997-02 $1,291,853 $77,511 WINN, ROBERT UNIVERSITY OF ILLINOIS AT CHICAGO
Total relevant funding to Breast for this search: $520,138,871
Showing 1 - 50 of 1829 results
Go to top